Disposable, instrument-free testing devices are used routinely for home and physician office testing, but present-day devices lack sensitivity and are limited in applicability to a small class of highly abundant analytes. Direct, unambiguous visual readout is an ideal way to deliver a result on a disposable test device; however, existing readout approaches require the accumulation of a high level of an analyte, and therefore only abundant analytes have been detected visually, which can be difficult to interpret without sophisticated laboratory equipment. Developing ways to link a visible, unambiguous color change to rare biological molecules remains an unmet need. Recently, a variety of direct visual readout strategies have been reported: these include approaches based on nanoparticles, plasmonic nanomaterials, 2D materials, and enzymatic reactions. Unfortunately, these approaches require interpretation of subtle color changes. This can make analyses operator-dependent, or, in other cases, diminishes the benefits of a test being instrument-free benefits by requiring a scanner device. Strategies for direct colorimetric readout of electric currents include paper-based electrochromism, electrochromic polymers, metal oxides, and fluorescent dyes. Electrochromic polymers and dyes allow for rapid and reversible color switching in response to electrical currents, but the currents required to switch areas detectable to the naked eye are above the threshold necessary for sensitive electrochemical detection. Inducing visible color changes using currents below 1 microampere is a fundamental challenge; for such currents fail to supply enough electrons to electrochemically reduce a visibly-perceptible quantity of electrochromic material. Directly translating such low currents into visible changes has yet to be achieved without the aid of costly, power-consumptive active electronics such as amplifiers.
Developing new, easy-to-interpret interfaces that convey diagnostic results obtained with low-abundance analytes would enable the development of low-cost diagnostics for a spectrum of new diseases.
Disclosed herein are systems and methods for detecting biomolecular analytes and outputting the results of the detection to a point-of-care device. In one aspect, the system and methods disclosed herein provide an easy-to-interpret platform for visually presenting the detection results. The systems and methods are applicable to any biomolecular analyte, including analytes in very low concentrations. In one aspect, the new approach, which we term electrocatalytic fluid displacement (EFD), transduces a molecular binding event into an electrochemical current that drives the electrodeposition of a metal catalyst. The catalyst promotes the formation of bubbles (for example, within a chamber of an electrochemical assay) that displaces a fluid within a chamber of the device to reveal a high contrast change. The readout system may be coupled to a nanostructured microelectrode or any suitable electrode. In some implementations, the system may be used to directly, visually detect nucleic acid sequences at concentrations lower than about 1 pM in about 10 minutes (e.g., in less than about 20 minutes, in less than about 15 minutes, in about 10-minutes to about 12 minutes, or in 10 minutes or less). This represents the lowest limit of detection of nucleic acids reported to date using high contrast visual readout. The rate of detection for a given concentration of an analyte can be adjusted (e.g., slowed or accelerated) by adjusting the rate of formation of the bubbles. In some implementations, the growth of the bubbles can be adjusted, for example, by tuning the concentration of peroxide in the chamber. Although the systems and methods disclosed herein are exemplified using the detection of nucleic acids, they may be adapted for the detection of other biomolecular analytes, such as proteins and small molecules. See, e.g., Jagotamoy et al., Nature Chemistry, 4, 642-648(2012), which is incorporated by reference in its entirety.
According to one aspect, there is provided a detection system for detecting a target analyte in a sample, the system comprises a first chamber comprising a sensor electrode capable of presenting a biomolecular probe at the surface of the sensor electrode. The probe is capable of binding the target analyte. The system further includes a second chamber comprising a readout electrode electrically coupled to the sensor electrode, a peroxide, and a metal catalyst.
According to one aspect, which may be combined with any of the systems or methods described herein, there is provided a method for detection of a target analyte in a sample, the method comprising: providing a detection system comprising: a first chamber comprising a sensor electrode having a probe affixed thereto, said probe capable of binding the analyte; a second chamber comprising a readout electrode electrically coupled to the sensor electrode; contacting the sensor electrode with the sample; adding peroxide and a metal catalyst to the second chamber, either simultaneously or sequentially; monitoring a color change in the second chamber; wherein the color change in the second chamber is indicative of the presence of the target analyte in the sample.
According to a further aspect, there is provided a point-of-care diagnostic device configured to perform any of the methods described herein. The point-of-care device may include one or more of the systems described herein, either alone or in combination.
According to a further aspect, there is provided a kit comprising: a sensor electrode capable of presenting a biomolecule probe at the surface thereof, said probe capable of binding a target analyte; a readout electrode electrically coupled to the sensor electrode; a peroxide; and a metal catalyst. The kit may include one or more of the systems described herein, and may be used to perform any of the methods described herein.
In some implementations of the systems and methods provided herein, the sensor electrode is a nanostructured microelectrode. Other sensor electrode structures can also be used, including planar surfaces, wires, tubes, cones and particles. Commercially available macro- and micro-electrodes are also suitable. In some implementations, the readout electrode is a mesh or high-edge-density electrode. In some implementations, the sensor electrode is electrically coupled to the readout electrode through a platinum wire electrode.
In some implementations of the systems and methods provided herein, the peroxide and metal catalyst are added to the second chamber sequentially. In some implementations, the peroxide and metal catalyst are added to the second chamber simultaneously. In some implementations, the metal catalyst is platinum.
In some implementations of the systems and methods provided herein, binding of the target analyte to the probe on the sensor electrode generates an electrical current that results in electrodeposition of the metal catalyst on the readout electrode. In some implementations, electrodeposition of the metal catalyst on the readout electrode causes decomposition of the peroxide present in the second chamber which generates oxygen bubbles. In some implementations, the analyte is nucleic acid. In some implementations, the probe is nucleic acids or peptide nucleic acids (PNAs). In some implementations, generation of bubbles displaces a dye present in the peroxide solution. In some implementations, generated bubbles displace a dye present in the peroxide solution. In some implementations, the second chamber comprises a colored spot beneath the readout electrode. In some implementations, visual detection of the colored spot beneath the readout electrode indicates a color change. In some implementations, the second chamber comprises a lid comprising a diffraction grating, wherein generation of bubbles causes an index mismatch at the diffraction grating, causing a structural color change. In some implementations, the second chamber comprises a lid comprising a diffraction grating, wherein generated bubbles cause an index mismatch at the diffraction grating, causing a structural color change. In some some implementations, the second chamber comprises a lid comprising a photonic structure, wherein generation of bubbles induces the appearance or disappearance or reduction of incoherent scattering, coherent scattering or iridescence, causing a structural color change. In some implementations, the second chamber comprises a lid comprising a photonic structure, wherein generated bubbles induce the appearance or disappearance or reduction of incoherent scattering, coherent scattering or iridescence, causing a structural color change. In some implementations, the lid of the second chamber is made of material having an index of refraction substantially the same as the peroxide. In some implementations, detection of light diffraction into its component indicates a color change. In some implementations, detecting a change in iridescence indicates a color change.
In some implementations of the systems and methods provided herein, the first chamber comprises a redox reporter comprising Ru(NH3)63+ and a reducing agent, wherein the reducing agent is not oxidizable or reducible by Ru(NH3)63+ or Ru(NH3)64+. In some implementations, the reducing agent is selected from: 3-mercaptopropionoic (MPA) acid, cysteamine (Cys), mercaptoethanol (MCE), cysteine, tris(2-carboxyethyl)phosphine (TCEP), and ethanolamine. In some implementations, the reducing agent comprises a combination of agents selected from: 3-mercaptopropionoic (MPA) acid+cysteamine (Cys); mercaptoethanol+cysteamine; cysteine+tris(2-carboxyethyl)phosphine (TCEP); ethanolamine+TCEP; cysteine+cysteamine; and ethanolamine+cysteamine.
In one aspect, this application provides a redox reporter system, comprising: a sensor electrode having a biomolecule probe affixed thereto, said probe is capable of binding a target analyte, such as a nucleic acid sequence; and an electrochemical redox reporter comprising Ru(NH3)63+ and a reducing agent, wherein the reducing agent is not oxidizable or reducible by Ru(NH3)63+ or Ru(NH3)64+. In some implementations, the reducing agent is selected from: 3-mercaptopropionoic (MPA) acid, cysteamine (Cys), mercaptoethanol (MCE), cysteine, tris(2-carboxyethyl)phosphine (TCEP), and ethanolamine. In some implementations, the reducing agent comprises a combination of agents selected from: 3-mercaptopropionoic (MPA) acid+cysteamine (Cys); mercaptoethanol+cysteamine; cysteine+tris(2-carboxyethyl)phosphine (TCEP); ethanolamine+TCEP; cysteine+cysteamine; and ethanolamine+cysteamine. In such implementations, the redox reporter system further comprises a readout or detection unit.
In yet another aspect, there is provided a method of detecting a target analyte, such as a nucleic acid sequence. The method includes providing a sensor electrode having a biomolecule probe affixed thereto. The probe is capable of binding a target analyte, such as a nucleic acid sequence. The method further includes contacting a sample comprising the analyte to the sensor electrode, and contacting the sensor electrode with an electrochemical redox reporter. The redox reporter may comprise Ru(NH3)63+ and a reducing agent. In some implementations, the reducing agent is not oxidizable or reducible by Ru(NH3)63+ or Ru(NH3)64+. The method further includes measuring a response signal from the sensor electrode using a readout or detection unit.
The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawings will be provided by the Office upon request and payment of the necessary fee.
The foregoing and other objects and advantages will be apparent upon consideration of the following detailed description, taken in conjunction with the accompanying drawings, in which like reference characters refer to like parts throughout, and in which:
Panel (B) shows comparison of ECC reporter systems using different reducing agents at DNA- or MCH-modified NMEs. (i) a,b: NMEs modified with MCH only; c,d: DNA modified NMEs with MPA+RuHex and MPA+RuHex+cysteamine respectively. (ii) a: NMEs modified with MCH only, with mercaptoethanol (MCE); b,c: DNA modified NMEs, with MCE+RuHex and MCE+RuHex+cysteamine respectively. (iii) a,b: NMEs modified with MCH only, with L-cysteine and L-cysteine+RuHex respectively; c,d: DNA modified NMEs, with L-cysteine+RuHex+TCEP and L-cysteine+RuHex+cysteamine respectively. (iv) a: NMEs modified with MCH only; b,c: DNA modified NMEs with ethanolamine+RuHex and ethanolamine+RuHex+cysteamine respectively. It is noted that any one or more the systems and processes discussed in the referenced figures can be combined. For example, systems described in
Disclosed herein are methods and systems to detect low-concentration analytes by transducing small electrochemical currents into easily perceived, high-contrast visual changes using a new approach termed electrocatalytic fluid displacement (EFD).
1. Overview of Electrocatalytic Fluid Displacement (EFD)
In one aspect, the EFD approach is based at least in part on the electrodeposition of a metal catalyst, such as platinum, that catalyzes peroxide (e.g., hydrogen peroxide) decomposition. An illustrative example of this electrodeposition process is shown in
In some implementations (which may be combined and used in conjunction with other implementations discussed herein), a mesh electrode at the bottom of a chamber serves as a template for electrodeposition of a metal catalyst upon the application of a current. Upon the introduction of hydrogen peroxide solution in the chamber, the metal catalyst catalyzes the decomposition of peroxide into water and oxygen, which forms a merging bubble (e.g.,
In some implementations (which may be combined and used in conjunction with other implementations discussed herein), the growing bubble displaces peroxide, which causes an index mismatch at a diffraction grating patterned in the underside of the chamber lid. Incident white light is diffracted into its component colors causing a structural color change. In certain implementations, the underside of the lid of the device may be patterned with other photonic structures such that the growing bubble induces either the appearance or disappearance of other forms of structural color including coherent scattering, incoherent scattering and iridescence.
In some implementations (which may be combined and used in conjunction with other implementations discussed herein), the catalyst induces a change in the light absorption properties or color of a dye molecule or pigment particle in solution. For example, many transition metal catalysts will catalyze a color change in the presence of a mixture of hydrogen peroxide and pigments such as hydroquinone, p-aminophenol, or 3,3′,5,5′-tetramethylbenzidine (TMB). See, e.g.,
In some implementations, to sense a nucleic acid sequence in a sample, the EFD system is connected to a sensor electrode that includes an immobilized nucleic acid probe. In some implementations, a nanostructured microelectrode (NME) is used, which acts as an ultrasensitive electrochemical biosensor (e.g.,
The NME sensors may be fabricated on silicon substrates using a two-step electrodeposition process as previously described. For example, in a gold nanostructured microelectrode, the gold microstructures protrude from the surface and reach into solution which increases the probability of interaction with the target molecules. The microstructures are decorated with a second layer of finely or roughly nanostructured gold. These nanoscale structures on the microelectrode surface with varying roughness enable additional surface area to immobilize probes and maximize sensitivity by enhancing the hybridization efficiency of the probe and target. Examples of such NME sensors are described in U.S. Pat. No. 8,888,969, which is hereby incorporated herein by reference in its entirety.
In some implementations, a multi-pronged strategy may be used to reduce (e.g., minimize) the current in the absence of target analyte. In an implementation, the sensors are functionalized using a charge-neutral probe, and the current read using a novel electrochemical assay described herein.
In implementations where the target analyte is a nucleic acid sequence, the sensors may be functionalized with thiolated nucleic acid probes (e.g., ribonucleic acids (RNA), deoxyribonucleic acids (DNA), or analog thereof, including, for example a peptide nucleic acid (PNA), locked nucleic acids, or phosphorodiamidate morpholino oligomers. In certain such implementations, the probe is a peptide nucleic acid (PNA) probes complementary to the target sequence. PNA is a synthetic nucleic acid analog which has a neutral charge. This neutral charge reduces or minimizes the background current and increases the signal-to-noise ratio. After target nucleic acid hybridization and washing, the sensor electrodes are subjected to an electrochemical redox reporter system in which an electrical current is generated per each nucleic acid hybridization event. The electrical current from the sensor drives the electrodeposition of platinum on an EFD reporter electrode, which results in degradation of the peroxide on the electrode forming a bubble that displaces the dye to reveal a colored spot beneath the electrode. As discussed above, in an alternative implementation, the growing bubble displaces peroxide, which causes an index mismatch at a diffraction grating patterned in the underside of the chamber lid. Incident white light is diffracted into its component colors causing a structural color change. When the target sequence is not present, the current is too low to deposit a sufficient amount of platinum to catalyze bubble formation or growth and no color change occurs.
As discussed above, the system disclosed herein may be implemented for the detection of other bioanalytes such as proteins and small molecules. In some implementations, the analyte of interest may be a small molecule, including but not limited to a therapeutic drug, a drug of abuse, environmental pollutant, and free nucleotides. In such implementations, the probe may be an aptamer configured to bind the small molecule. In some implementations, the analyte of interest may be a protein or protein fragment. In such implementations, the probe may be an aptamer configured to bind to the protein or protein fragment. In certain implementations, the analyte of interest may be an uncharged molecule. In certain implementations, the analyte is a small molecule with a molecular weight of less than about 500 Daltons.
In some implementations, the electrochemical reporter system is an electrocatalytic reporter pair comprising Ru(NH3)63+ and Fe(CN)63−. Ru(NH3)63+ is electrostatically attracted to a target analyte, such as a negatively-charged phosphate backbone of nucleic acid sequence, that binds to the probes immobilized on the surface of sensor electrodes and is reduced to Ru(NH3)62 when the electrode is biased at the reduction potential. The Fe(CN)63− present in solution chemically oxidizes Ru(NH3)62+ back to Ru(NH3)63+ allowing for multiple turnovers of Ru(NH3)63+, which generates an high electrocatalytic current. This reporter system may be used in conjunction with differential pulse voltammetry.
In some implementations, a DC potential may be used for readout instead voltammetry (although voltammetry may be suitable in some implementations). Since the Ru(NH3)63+ and Fe(CN)63− system produce high background currents using DC potential amperometry, a novel Electrochemical-Chemical-Chemical (ECC) redox reporter system is provided that eliminates or reduces interfering redox reactions near the potential of interest. Accordingly, in some implementations, the electrochemical reporter system is the novel ECC redox cycle reporter system described below.
2. ECC Redox Cycle Reporter System
Further provided herein is a new ECC redox reporter system and method for using the same. In one aspect, the new ECC redox cycle reporter system radically amplifies the current generated from target nucleic acid hybridization. To the best of the inventors' knowledge, this is the first reported use of ECC for the detection of nucleic acids to date. In one aspect, the ECC system includes a redox molecule that is electrostatically attracted to the backbone of the bound target nucleic acids and reducing agents which regenerate the original form of the redox molecule in order to amplify the signal. See, e.g.,
In some implementations, the reducing agents are not oxidizable at the electrode surface in order to reduce the background current. In some implementations, the reducing agents are not oxidizable or reducible by Ru(NH3)63+ or Ru(NH3)64+. In some implementations, the relationship between the formal potentials of the ECC system species may be characterized as follows:
Electrode<Ru(NH3)63+,Ru(NH3)64+,<R1,R1(OX), or R2, R2(OX).
Reducing agents which may be used in the ECC system include, but are not limited to, 3-mercaptopropionoic (MPA) acid, cysteamine (Cys), mercaptoethanol (MCE), cysteine, tris(2-carboxyethyl)phosphine (TCEP), and ethanolamine. In some implementations, signal amplification using ECC is achieved using a single reducing agent as opposed to a pair of reducing agents, although a larger concentration of reducing agent must be used. However, systems with two reducing agents have been found to produce lower background currents. Accordingly, in some implementations, signal amplification using ECC is achieved using a pair of reducing agents. Pairs of reducing agents which may be used in the ECC system include but are not limited to: 3-mercaptopropionoic (MPA) acid and cysteamine (Cys); mercaptoethanol and cysteamine; cysteine and tris(2-carboxyethyl)phosphine (TCEP); ethanolamine and TCEP; cysteine and cysteamine; and ethanolamine and cysteamine. See
In some implementations, the ECC redox system employs Ru(NH3)63+, mercaptopropionic acid (MPA), and cysteamine. Ru(NH3)63+ is electrostatically attracted to the negatively-charged phosphate backbone of the bound target nucleic acids. Upon the application of an appropriate potential (250 mV in this example), Ru(NH3)63+ is oxidized to Ru(NH3)64+. The MPA present in solution chemically reduces Ru(NH3)64+ back to Ru(NH3)63+, allowing for multiple turnovers of Ru(NH3)63+, which generates a high electrocatalytic current. This signal is further amplified by cysteamine, another reducing agent, which is chemically oxidized to cystamine by reducing the oxidized-form of MPA (R-S-S-R) back to its reduced form (R-SH).
In some implementations, in the presence of a target analyte (e.g., nucleic acids), the current drives the electrodeposition of platinum on the EFD electrode which catalytically forms a bubble that displaces the dye to reveal the colored spot. When the target analyte is not present, the current is too low to deposit a sufficient amount of platinum to catalyze bubble growth and no color change occurs (
In some implementations (which may be combined with any of the above-referenced implementations), in the presence of a target analyte (e.g., nucleic acids), the current drives the electrodeposition of platinum on the EFD electrode which catalytically forms a bubble that displaces peroxide, which causes an index mismatch at a diffraction grating patterned in the underside of the chamber lid. Incident light is diffracted into its component colors causing a structural color change. When the target sequence is not present, the current is too low to deposit a sufficient amount of platinum to catalyze bubble growth and no detectable color change occurs (
3. A Comparative Model of Color Change Resultant from EFD
Catalytic electrochromic transduction methods offer significant signal amplification needed for transducing the ultra-low currents generated by the ECC assay compared to direct electrochromic reduction. To study the prospective performance of this approach, we calculated the predicted time required to induce a visible color change using a variety of transduction strategies.
We illustrate the challenge of directly inducing a color change by considering the example of electrodepositing an optically-discernible quantity of metal. A current of about 1 nA applied for about 10 s supplies about 6×1010 electrons which can turnover a maximum of 6×1010 molecules. Even under the generous assumption that a single molecular layer is visible, given an atomic radius of about 1 Å, this yields a spot of only about 50 μm×about 50 μm. This is too small to be easily visible to the naked eye as the spatial resolution of human eyesight is approximately about 100 to about 200 μm.
The EFD detection systems and methods provided herein are capable of amplifying, by orders of magnitude, the color change per charge. In one aspect, a catalyst, such as platinum, is electrodeposited to turn on the colorimetric reaction. By depositing a catalyst, each electron effectively converts multiple molecules, amplifying the color transformation. However, as
Thus, in some implementations, instead of catalytic reduction of a solution-based pigment, a gaseous substance is used, as an equivalent molar amount of gas occupies a much larger volume than a liquid. At standard temperature and pressure (STP), the volume of about 1 mole of gas is about 22.4 L, which is about 3 orders of magnitude larger than a mole of liquid H2O (18 mL). Platinum is an excellent catalyst for the decomposition of hydrogen peroxide to form oxygen and water. As
4. Optimization of Device Geometry
In one aspect, the electrocatalytic fluidic displacement approach may be implemented using a rectangular gold electrode patterned on a glass substrate which sits at the bottom of a chamber. The chamber may be any suitable size, e.g., a circular chamber of about 50 μm tall by about 1.5 mm wide. After depositing platinum for about 10 s at about 1 nA, a hydrogen peroxide solution is introduced and the rate of bubble growth is measured using, e.g., a microscope (See, e.g., FIG. 2A). Bubbles are formed preferentially at the electrode edges, without observable rapid growth.
In one implementation, mesh shaped electrodes with increased ratios of edges to surface area were designed and fabricated to test the enhancement provided by edges. About 1 nA current was applied for about 10 s to deposit platinum and the rate of bubble growth was recorded (
The average growth of the bubble for various applied currents was measured using the high density mesh electrodes.
5. Electrocatalytic Fluidic Dye Displacement
In some implementations, to induce a visible color change that is easily interpretable by the end-user, a bubble is used to displace an opaque dye that obscures a colored spot beneath the readout window. As the chamber fills with oxygen, the colored spot is revealed.
In this implementation, increasing the dye concentration increased the opacity of the dye, but also increased its viscosity. At higher viscosities, bubble formation was inhibited (See, e.g.,
In some implementations, to determine the minimum visibly detectable current, platinum was deposited at various rates for about 10 s and the exposed area of the blue spot was measured (See, e.g.,
The spatial resolution of human eyesight is about 200 μm, making the smallest visible area approximately about 200 μm×about 200 μm or about 0.04 mm2. Thus, the spot area of about 0.09 mm2 obtained from a current of about 1 nA after about 5 minutes is visible to the naked eye.
To quantify the performance of the device, the coloration efficiency (CE) may be calculated as follows:
6. Electrocatalytic Fluidic Induction of a Structural Color Change
As optical absorbance increases with path length, the readout window may need to be sufficiently tall for the dye to obscure the colored spot beneath. As such, the response time of a colorimetric device based on dye displacement can vary depending on the path length as the bubble needs to grow large enough to reach the chamber ceiling.
According to one aspect, by patterning substrates with feature sizes on the order of the wavelength of light, it is possible to produce vibrant structural colors. Examples of this include diffraction gratings and iridescence. The color of the substrate can be modified by matching the index refraction between a second medium and the substrate. By exploiting a structural color change, the readout turnaround time can be decreased. As structural color changes rely on the index matching at an interface, the color change is largely independent of the path length through the index-matching medium. Thus, a vibrant color change is expected, using a device with a much smaller channel height than required when using dye displacement. As the substrate provides the color, there is no need to increase the opacity of the peroxide by introducing additional compounds which might interfere with the reaction. In one implementation of this approach, a diffraction grating is patterned into the underside of the PDMS lid affixed to the top of the device with a channel about 7 μm tall. As the index of refraction of peroxide (n=1.35) is similar to that of PDMS (n=1.4), the diffraction grating is invisible to incoming light when the device is initially loaded with peroxide. As the bubble is formed, the peroxide is replaced with O2 which has an index of refraction of 1. This index mismatch between the bubble and PDMS unveils the diffraction grating. The incident white light is diffracted into its component colors to reveal the circular spot. In certain implementations, the change or appearance of diffraction induced by this refractive index change may be read out by the spatial pattern of light spots reflected or transmitted from a monochromatic source such as a laser in a barcode scanner.
7. Colorimetric Readout of ssDNA
In one implementation, to test the capability of the EFD device to detect biomarkers, NME sensors are connected in serial to the EFD readout chip and with ssDNA. As an initial characterization of the ECC assay, the sensors were challenged with serial dilutions of ssDNA. The corresponding currents were measured after applying about 250 mV (
In some implementations, in order to demonstrate colorimetric readout of biomarkers, the assay was coupled to a readout device and the sensors were challenged with serial dilutions of ssDNA. The NME sensors were immersed in the ECC solution and the EFD readout device in the platinum electrodeposition solution, thereby connecting the sensors to the EFD device. However, other methods of coupling the sensors to the EFD device may be used. A platinum wire electrode immersed in the ECC solution was connected to a second platinum electrode in the electrodeposition bath, to bridge electronically the sensor and readout device. See, e.g.,
In one implementation, the peroxide concentration was optimized to minimize bubble formation from currents at the background level. Bubble growth at low currents could be suppressed using about 10% peroxide (
In one implementation, the rate of color change using direct colorimetric readout was calculated under the assumption that a channel about 50 μm tall by about 200 μm wide was filled with enough electrochromic dye to give an OD of about 1. It was further assumed that a high molar absorptivity of about 1×107 M−1m−1 which is similar to that of malachite green. The time needed to turn over the dye in the channel was calculated using the catalysis rate of platinum.
In one implementation, the rate of bubble formation was calculated using electrocatalytic fluidics in a chamber that is about 50 μm tall with a about 200 μm width. The rate of oxygen formation was calculated using the catalysis rate of platinum. The onset of bubble formation occurred as peroxide in the chamber was saturated with oxygen. It was assumed that the bubble is visible once it grows to the volume of the chamber.
In one implementation, the device was fabricated using standard photolithographic methods. Briefly, electrodes were patterned on a glass substrate. The device was passivated using SU-8 2002 (Microchem, Newton, Mass.) and apertures were patterned to expose the electrodes below. The channel was fabricated by patterning SU-8 3050.
In one implementation, the electrode was immersed in K2PtCl4 and connected to an Epsilon potentiostat (BASi West Lafayette, Ind.) using a 3-electrode setup with a Ag/AgCl reference electrode and a Pt counter electrode. Using chronopotentiometry, various currents were applied for about 10 s. After electrodeposition, the device was washed thoroughly with H2O and covered with a PDMS lid.
In one implementation, about 100 μL of white dye (Liquitex Titanium White Ink) was centrifuged for about 5 minutes at about 15 000 g. The supernatant was removed and replaced with about 4004 of about 30% H2O2 (Sigma). The dye (about 25 pg/mL) was introduced into the channel and the amount of bubble generation was measured over time using a camera (Canon).
In one implementation, a diffraction grating was patterned in PDMS by curing PDMS on a DVD-R. The PDMS diffraction grating lid was removed and attached to the device with an about 7 μm tall channel. About 27% H2O2 with about 1% pluoronic (Sigma) was introduced into the device and color changes were measured over time using a camera (Canon).
In one implementation, six inch silicon wafers were passivated using a thick layer of thermally grown silicon dioxide and coated with a Ti adhesion layer of about 25 nm. A gold layer of about 350 nm was deposited on the chip using electron-beam-assisted gold evaporation which was again coated with about 5 nm of Ti. The electrodes were patterned in the metal layers using standard photolithography and a lift-off process. A layer of about 500 nm of insulating Si3N4 was deposited using chemical vapor deposition. Apertures of about 5 μm were etched at the tips of the metal leads using standard photolithography. Contact pads (about 0.4 mm×about 2 mm contact) were patterned using wet etching as well.
In some implementations, chips were cleaned by sonication in acetone for about 5 min, rinsed with isopropyl alcohol and DI water, and dried with nitrogen. Electrodeposition was performed at room temperature. Apertures of about 5 μm on the fabricated electrodes were used as the working electrodes and were contacted using the exposed bond pads. Nanostructured microelectrodes sensors were electrodeposited in a solution of about 50 mM HAuCl4 and about 0.5 M HCl using DC potential amperometry at about 0 mV for about 100 s. After washing with DI water and drying, the sensors were coated again with a thin layer of Au to form nanostructures by plating at about −450 mV for about 10 s.
In one implementation, an aqueous solution containing about 1 μM of probe (5′-GGT CAG ATC GTT GGT GGA GT-3′) was mixed with about 10 μM of aqueous Tris(2-carboxyethyl)phosphine hydrochloride solution and then the mixture was left for overnight to cleave disulphide bonds. After mixing about 100 nM of 6-mercaptohexanol (MCH) to this probe solution mixture, about 20 μL was pipetted onto the chips and incubated for about 3 h in a dark humidity chamber at room temperature for probe immobilization. The chips were then washed thrice for about 5 min with 0.1×PBS at room temperature. The chips were then treated with about 1 mM MCH for an hour at room temperature for back filling. After washing, the chips were challenged with different concentration of targets for about 30 min at room temperature. After hybridization, the chips were washed thrice for about 5 min with about 0.1×PBS at room temperature and the electrochemical scans were acquired.
In some implementations, electrochemical experiments were carried out using a Bioanalytical Systems Epsilon potentiostat with a three-electrode system featuring a Ag/AgCl reference electrode and a platinum wire auxiliary electrode. Electrochemical signals were measured in a Tris buffer solution (about 50 mM, pH of about 9) containing about 10 μM [Ru(NH3)6]Cl3, about 0.5 mM 3-mercaptopropionoic acid (MPA), and about 0.5 mM cysteamine (Cys). DC potential amperometry (DCPA) signals were obtained at about +250 mV for about 10 s. Signal changes, ΔI, were calculated with ΔI=Ic−I0 (where Ic is the current at a given concentration and I0 is the current without analyte).
Variations and modifications will occur to those of skill in the art after reviewing this disclosure. The disclosed features may be implemented, in any combination and subcombination (including multiple dependent combinations and subcombinations), with one or more other features described herein. The various features described or illustrated above, including any components thereof, may be combined or integrated in other systems. Moreover, certain features may be omitted or not implemented. All references cited are hereby incorporated by reference herein in their entireties and made part of this application.
Examples of changes, substitutions, and alterations are ascertainable by one skilled in the art and could be made without departing from the scope of the information disclosed herein. All references cited herein are incorporated by reference in their entirety and made part of this application.
This claims priority to U.S. Provisional Application No. 62/138,827, filed Mar. 26, 2015, which is hereby incorporated herein by reference in its entirety. This application is related to PCT Application No. ______, filed Mar. 28, 2016 (Attorney Docket No. 109904-0026-WO1), which is hereby incorporated herein by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
62138827 | Mar 2015 | US |